Citadel Advisors »

Capricor Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Capricor Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Capricor Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capricor Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $190k 39k 4.89
2023-09-30 $227k 66k 3.42
2023-06-30 $268k 56k 4.78
2023-03-31 $419k 99k 4.22
2022-12-31 $983k 255k 3.86
2022-06-30 $0 220k 0.00
2022-03-31 $761k 219k 3.48
2021-12-31 $693k 236k 2.93
2021-09-30 $1.1M 279k 4.02
2021-06-30 $1.2M 225k 5.12
2021-03-31 $805k 172k 4.69
2020-12-31 $474k 138k 3.43
2020-09-30 $638k 122k 5.25
2020-06-30 $346k 75k 4.61
2020-03-31 $28k 24k 1.17
2019-12-31 $15k 11k 1.32